Focused Team. One Purpose.
Auron Therapeutics is a patient-centered, platform-powered oncology company developing therapies that target cell-state plasticity — the root driver of cancer and inflammatory disease. Its proprietary AURIGIN platform uses AI and single-cell genomics to identify novel drug targets. Lead program AUTX-703 is in clinical development for AML and other hematologic malignancies.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account